117 filings
8-K
CCXI
ChemoCentryx Inc
20 Oct 22
Amgen Successfully Completes Acquisition of Chemocentryx
9:20am
8-K
CCXI
ChemoCentryx Inc
18 Oct 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
CCXI
ChemoCentryx Inc
19 Sep 22
Other Events
9:23pm
8-K
CCXI
ChemoCentryx Inc
4 Aug 22
Amgen to Acquire Chemocentryx for $4 Billion In Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine
8:16am
8-K
CCXI
ChemoCentryx Inc
5 Jul 22
ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director
8:48am
8-K
g9f28
9 Jun 22
Departure of Directors or Certain Officers
4:40pm
8-K
v0oegtzl1242dtxol3
1 Jun 22
ChemoCentryx Announces Changes to its Board of Directors
4:36pm
8-K
ufm97y
5 May 22
ChemoCentryx Reports First Quarter 2022 Financial Results and Recent Highlights
12:00am
8-K
u8iqb3opvew7
3 May 22
Other Events
11:35am
8-K
nvf8q276u r5
1 Mar 22
ChemoCentryx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
4:15pm
8-K
vbe519hkvfcfhb
28 Feb 22
Departure of Directors or Certain Officers
12:00am
8-K
pi3lwmaplgs9m
12 Nov 21
Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by
10:40am
8-K
8i5640s5 o08grq
9 Nov 21
ChemoCentryx Reports Third Quarter 2021 Financial Results and Recent Highlights
12:00am
8-K
uhof2 7koiyssbkr2x
12 Oct 21
ChemoCentryx Appoints Rita I. Jain, M.D. as Executive Vice President, Chief Medical Officer
6:17am
8-K
ngjrt sga4e4aay6dj
8 Oct 21
ChemoCentryx Announces FDA Approval of TAVNEOSTM (avacopan) in ANCA-Associated Vasculitis
11:24am
8-K
edyh6d9u7utetuvi9vvl
27 Sep 21
ChemoCentryx Announces Approval in Japan of TAVNEOSTM (Avacopan) for the Treatment of ANCA-Associated Vasculitis
11:04am
8-K
hsapaop
9 Aug 21
ChemoCentryx Reports Second Quarter 2021 Financial Results and Recent Highlights
4:34pm
8-K
yg848fnm02a
6 Jul 21
Regulation FD Disclosure
10:06am
8-K
153kjmp
24 May 21
Submission of Matters to a Vote of Security Holders
12:54pm
8-K
53z0w
7 May 21
ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis
2:56pm